## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `nad-plus-stimulants`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/nad-plus-stimulants/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/nad-plus-stimulants/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/nad-plus-stimulants/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/nad-plus-stimulants/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/nad-plus-stimulants/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `nad-plus-stimulants` v2 · content_hash `e22b96a94ac17d04…` · thread_head genesis · 35 DIVs
- **thesis (c1):** Semax increases BDNF levels in rat basal forebrain after intranasal application.
  - c2 [human/active] Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients.
  - c3 [preclinical/active] DSIP reduced amphetamine-induced hyperthermia in mice at certain doses.
  - c4 [preclinical/active] NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models.
  - c5 [anecdotal/active] Small human trials link intravenous NAD to substance use disorder recovery observations.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/nad-plus-stimulants/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/nad-plus-stimulants/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `nad-plus-stimulants`
- **title:** NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers
- **url:** https://miscsubjects.com/a/nad-plus-stimulants
- **register:** source_ledger
- **updated:** 2026-07-17T02:40:44.998Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have Stimulant load (Adderall / amphetamine)

Amphetamines force dopamine and norepinephrine release. This borrows focus now.

Sleep, appetite, and gut lining often suffer. Less regeneration window follows.

Chronic load can deplete neurochemistry and stress the gut-brain axis.

Four layers show the mismatch between breakdown and repair:

- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.
- Sleep: Stimulants delay onset and cut deep sleep stages.
- Gut: Mucosa faces stress; inflammation feeds back to mood and cognition.
- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.

## Why Semax might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.

## Why Selank might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. Layer breaking down: Anxiety — Arousal without calm leads to jitter, rumination, non-restorative stress.
3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

## Why DSIP might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
4. Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.

## Why NAD+ might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.

## Why Amphetamine stimulants matters for you

1. Drug: Amphetamine stimulants.
2. What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
3. Therefore for you: This drug suppresses signals of fatigue and suppresses repair windows. It trades short-term focus for longer-term depletion of neurochemistry and sleep architecture.

## How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.
- Semax targets neural / cognitive.
- Selank targets anxiety / neurochemistry.
- DSIP targets sleep / repair window.
- NAD+ targets cellular energy.

The stack maps distinct layers without overlap in primary action. Semax addresses BDNF and dopamine-related fatigue. Selank addresses arousal excess. DSIP widens the deep-sleep window stimulants shrink. NAD+ supports mitochondrial energy that stimulants can tax. Together they address separate points where breakdown exceeds repair.

## What the evidence actually shows

Human data exist for Selank in generalized anxiety disorder. One trial compared it to medazepam in 62 patients and found comparable anxiolytic effects with additional cognitive benefits (source s12). Another small trial noted rapid response in some GAD patients (source s10).

Semax has animal data showing increased BDNF in rat basal forebrain and hippocampus after intranasal dosing (source s6, source s0). A hypothesis paper links this to potential ADHD relevance via dopamine and BDNF pathways (source s1). One Russian pediatric report mentioned in secondary sources noted behavioral improvements in half of ADHD cases, but no large Western RCT confirms this (source s3, source s5).

DSIP reduced amphetamine-induced hyperthermia in mice in one 1984 study (source s15). Human sleep studies are small and mixed; early trials reported increased delta sleep pressure in volunteers, yet results vary (source s16, source s18).

NAD+ shows preclinical mitochondrial support and some observational links to addiction recovery pathways (source s19). Small older human reports on intravenous NAD for substance issues exist but lack modern controls (source s21). No direct human trials tie NAD+ specifically to amphetamine recovery.

## What scientists say

Researchers note Semax augments psychostimulant effects on dopamine in animals while raising BDNF (source s1). Selank trials emphasize GABAergic modulation without sedation (source s12). DSIP literature describes it as sleep-promoting rather than sedative (source s16). NAD+ reviews highlight its role in energy metabolism and potential in substance contexts, while calling for more controlled human data (source s19, source s20).

## What people say on Reddit

Users report stacking Semax with Selank for focus and calm while on or after stimulants. Some describe improved task management and reduced jitter (source s29, source s32). DSIP threads mention deeper sleep perception. NAD+ appears in stacks for energy recovery but with variable subjective notes (source s33, source s34).

## What people say on X

Limited direct posts in available data; discussions echo Reddit patterns on peptide stacks for stimulant side effects, often anecdotal.

## What we do not know

No large-scale Western randomized controlled trials exist for any of these compounds specifically in stimulant recovery populations. Human evidence for Semax in ADHD remains limited to non-English or small datasets. DSIP and NAD+ human data for this exact context stay sparse or absent. Long-term safety and interaction profiles with ongoing amphetamine use lack dedicated study.

## Safety and limits

All compounds discussed here carry limited regulatory approval outside specific regions. Evidence grades remain mostly preclinical or small human for anxiety/sleep indications. Individual responses vary. This article inventories published observations only.

## Claims (5)

- **c2** [human w=0.8] Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients.
  - who_claims: grok/grok-4.3
  - sources: s12
- **c1** [preclinical w=0.5] Semax increases BDNF levels in rat basal forebrain after intranasal application.
  - who_claims: grok/grok-4.3
  - sources: s6, s0
- **c3** [preclinical w=0.5] DSIP reduced amphetamine-induced hyperthermia in mice at certain doses.
  - who_claims: grok/grok-4.3
  - sources: s15
- **c4** [preclinical w=0.5] NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models.
  - who_claims: grok/grok-4.3
  - sources: s19
- **c5** [anecdotal w=0.3] Small human trials link intravenous NAD to substance use disorder recovery observations.
  - who_claims: grok/grok-4.3
  - sources: s21

## Voxel graph (5 atoms · 11 edges)
- full graph: https://miscsubjects.com/api/articles/nad-plus-stimulants/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (7)
- chain valid: yes · head: `720177cd5370423c`

### s0 · pubmed · ok
- title: Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome
- url: https://pubmed.ncbi.nlm.nih.gov/16996699/
- summary: Reviews Semax effects including BDNF in animals.
- quote: It has been found to stimulate memory and attention in rodents and humans after intranasal application.
- claim_ids: c1
- hash: `51dd87e0e113556e`

### s6 · pubmed · ok
- title: Semax, an analogue of adrenocorticotropin (4-10), binds specifically to the rat basal forebrain
- url: https://pubmed.ncbi.nlm.nih.gov/16635254/
- summary: Direct rat BDNF measurement after Semax.
- quote: Sandwich immunoenzymatic analysis revealed that Semax applied intranasally at 50 and 250 microg/kg bodyweight resulted in a rapid increase in BDNF levels after 3 h in the basal forebrain
- claim_ids: c1
- hash: `103bb95be0ebdba5`

### s12 · pubmed · ok
- title: Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank
- url: https://pubmed.ncbi.nlm.nih.gov/18454096/
- summary: Human GAD trial results.
- quote: Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam
- claim_ids: c2
- hash: `eb4e7d0f36c83146`

### s15 · pubmed · ok
- title: DSIP reduces amphetamine-induced hyperthermia in mice
- url: https://pubmed.ncbi.nlm.nih.gov/6548818/
- summary: Animal thermoregulation data with amphetamine.
- quote: It was reported that DSIP reversed the increase in temperature of rats injected at room temperature with 15 mg d-amphetamine per kg body weight.
- claim_ids: c3
- hash: `d86e27e1fa46e458`

### s19 · other · ok
- title: Sobriety and Satiety: Is NAD+ the Answer?
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC7278809/
- summary: Reviews NAD+ in addiction models.
- quote: These studies implicate raising intracellular NAD+ levels as a potential target for managing and treating addictive behaviour and reducing cravings
- claim_ids: c4
- hash: `e33cbdf4c0839443`

### s21 · medical · ok
- title: NAD Therapy for Addiction: What to Know
- url: https://www.webmd.com/mental-health/addiction/nad-therapy-addiction
- summary: Summarizes historical NAD observations in substance issues.
- quote: The first study testing NAD for substance use disorders came out many decades ago. The doctor who did the study gave NAD in an IV to more than 100 people with alcohol use disorder, opioid use disorder, or other substance use disorders.
- claim_ids: c5
- hash: `720177cd5370423c`

### s1 · review · http_403
- title: Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder
- url: https://www.sciencedirect.com/science/article/abs/pii/S0306987706005391
- summary: Proposes Semax for ADHD based on dopamine and BDNF data.
- quote: Evidence from animal studies revealed that Semax can augment the effects of psychostimulants on central dopamine release and also stimulates central brain-derived neurotrophic factor (BDNF) synthesis.
- hash: `a3e825323e254a5b`

## Provenance (2 model passes)
- chain valid: yes · head: `94d293c7b33317da`

- write · grok/grok-4.3 · 2026-06-30T01:41 · hash `317f4f31293e`
- voxel_divide · owner · 2026-07-17T02:40 · hash `94d293c7b333`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/nad-plus-stimulants/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/nad-plus-stimulants/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"nad-plus-stimulants","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest nad-plus-stimulants|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim nad-plus-stimulants|tier|assertion`
- **iMessage ask:** `nad-plus-stimulants|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `nad-plus-stimulants`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/nad-plus-stimulants/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*